Related references
Note: Only part of the references are listed.Study of adherence comes to the treatment of chronic hepatitis B
Maximilian Lee et al.
JOURNAL OF HEPATOLOGY (2011)
Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B
Watcharasak Chotiyaputta et al.
JOURNAL OF HEPATOLOGY (2011)
Renal Dysfunction in Chronic Hepatitis B Patients Treated with Adefovir Dipivoxil
Nghi B. Ha et al.
HEPATOLOGY (2009)
Long-Term Monitoring Shows Hepatitis B Virus Resistance to Entecavir in Nucleoside-Naive Patients Is Rare Through 5 Years of Therapy
Daniel J. Tenney et al.
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update
Emmet B. Keeffe et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: Recommendations for a standardized approach
Jean-Michel Pawlotsky et al.
GASTROENTEROLOGY (2008)
Treatment of hepatitis B: the next five years
E. Jenny Heathcote
CLINICAL MEDICINE (2007)
Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B
Chia-Yen Dai et al.
ANTIVIRAL RESEARCH (2007)
Antiviral drug-resistant HBV: Standardization of nomenclature and assays and recommendations for management
Anna S. Lok et al.
HEPATOLOGY (2007)
Health beliefs, disease severity, and patient adherence - A meta-analysis
M. Robin DiMatteo et al.
MEDICAL CARE (2007)
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
Stephanos J. Hadziyannis et al.
GASTROENTEROLOGY (2006)
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
CL Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Epidemiology and natural history of hepatitis B
BJ McMahon
SEMINARS IN LIVER DISEASE (2005)
Chronic hepatitis B: Update of recommendations
ASF Lok et al.
HEPATOLOGY (2004)
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
D Lavanchy
JOURNAL OF VIRAL HEPATITIS (2004)
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine
DJ Tenney et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Medication compliance feedback and monitoring in a clinical trial: Predictors and outcomes
J Cramer et al.
VALUE IN HEALTH (2003)
Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase
P Angus et al.
GASTROENTEROLOGY (2003)
Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: Analysis and review of the literature
H Mommeja-Marin et al.
HEPATOLOGY (2003)
Helping patients follow prescribed treatment - Clinical applications
RB Haynes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Strategies for optimizing adherence to highly active antiretroviral therapy: Lessons from research and clinical practice
VE Stone
CLINICAL INFECTIOUS DISEASES (2001)
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
DL Paterson et al.
ANNALS OF INTERNAL MEDICINE (2000)
Long-term patient adherence to antiretroviral therapy
NJ Ostrop et al.
ANNALS OF PHARMACOTHERAPY (2000)
Factors affecting adherence to antiretroviral therapy
MA Chesney
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
